Genentech Incorporated

CONGLOMERATES GE lending unit to be restructured General Electric Co. said it was reorganizing its GE Capital unit to save $2 billion next year, a move it said would lead to job cuts as it restructured and shrank the lending unit battered by the credit...

Health-care stocks often are seen as a haven when the economy slows, but they've struggled lately. Nonetheless, they still have managed to outperform the broader market. No matter what the state of the economy, the demand for many health-care products...

OSI Pharmaceuticals Inc. of Melville and its partners in an anti-lung cancer drug said Friday that results of a new study they conducted showed the medication, Tarceva, helped slow the progress of the disease when given immediately after chemotherapy....

OSI Pharmaceuticals Inc. of Melville and Genentech Inc., its partner in an anti-cancer drug, said Monday a combination of Genentech's Avastin and OSI's Tarceva failed in a study to prolong the lives of patients with the most common form of lung cancer....

The one thing Kevin Carlberg refused to face after his diagnosis with brain cancer in 2002 was anyone's estimate for how long he might live. His doctors and his family all knew the number: six to 18 months. "I understand the averages," says Carlberg,...

Intel Corp.'s third-quarter profit rose 12%, edging past Wall Street's estimates, but the chip maker cautioned that the pall the financial crisis had cast over the technology sector had made it hard to predict its results for the current period. The...

At a glance Today Government offices are closed for Columbus Day. Bond markets are closed. Nobel memorial prize in economics is announced in Stockholm. Tuesday Weekly Treasury auction and briefing. Quarterly earnings reports due from Genentech,...

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000? In the case of Genentech Inc.,...

Buoyed by sales of the anti-cancer drug Tarceva, OSI Pharmaceuticals Inc. said its sales and profits were up for the second quarter of 2007. The company, based in Melville, said after the close of trading Wednesday that sales were $95.7 million for the...

Monday: -- Earnings: Genentech Inc.; M&T Bank Corp. Tuesday: -- December retail sales -- December producer price index -- November business inventories -- Earnings: Citigroup Inc.; Forest Laboratories Inc.; H.B. Fuller Co.; Intel Corp.; Linear Technology...

Shortly after the Sept. 11, 2001, terrorist attacks and the subsequent anthrax mailings, top U.S. science advisors said the country "urgently needed" a new, improved anthrax vaccine. The existing vaccine often caused swollen arms and muscle and joint...

Q: I'm not sure what to make of Alcoa Inc. Should I keep its shares in my portfolio? --K.G., via the Internet A: The world's largest aluminum producer is expected to turn in record revenues for the next couple of years. Global demand for aluminum is...